Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

SHA:688076 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,676	11,411	9,583	4,890	8,811	-
Market Cap Growth	-2.89%	19.08%	95.95%	-44.50%	-	-
Enterprise Value	12,204	12,107	9,772	4,726	8,238	-
Last Close Price	33.78	36.56	31.40	15.94	28.55	-
PE Ratio	20.96	28.22	58.81	37.88	76.36	-
Forward PE	15.86	20.25	50.65	31.86	30.20	-
PS Ratio	5.62	7.02	9.27	7.51	13.68	-
PB Ratio	3.41	4.25	4.38	2.54	4.87	-
P/TBV Ratio	3.84	4.76	5.04	2.95	5.64	-
P/OCF Ratio	20.64	28.52	27.36	166.95	48.75	-
EV/Sales Ratio	6.42	7.45	9.46	7.26	12.79	-
EV/EBITDA Ratio	14.43	18.27	30.27	27.72	41.45	-
EV/EBIT Ratio	20.91	26.27	51.15	65.84	70.35	-
Debt / Equity Ratio	0.82	0.61	0.41	0.17	0.05	0.26
Debt / EBITDA Ratio	3.06	2.45	2.74	1.86	0.41	1.23
Debt / FCF Ratio	-	-	-	-	-	8.24
Net Debt / Equity Ratio	0.48	0.32	0.07	-0.06	-0.33	0.10
Net Debt / EBITDA Ratio	1.79	1.30	0.45	-0.72	-3.00	0.49
Net Debt / FCF Ratio	-1.59	-1.25	-0.47	0.30	11.32	3.26
Asset Turnover	0.34	0.38	0.34	0.28	0.37	0.43
Inventory Turnover	0.99	1.20	1.27	1.07	1.41	1.66
Quick Ratio	0.87	0.76	1.08	1.26	2.99	0.69
Current Ratio	1.34	1.14	1.54	1.91	4.01	1.28
Return on Equity (ROE)	17.16%	16.41%	8.04%	6.58%	7.84%	13.30%
Return on Assets (ROA)	6.55%	6.68%	3.93%	1.93%	4.15%	6.22%
Return on Invested Capital (ROIC)	11.97%	14.29%	8.82%	4.75%	8.90%	10.50%
Return on Capital Employed (ROCE)	12.60%	13.90%	7.40%	3.60%	6.30%	13.00%
Earnings Yield	4.67%	3.54%	1.70%	2.64%	1.31%	-
FCF Yield	-8.87%	-6.05%	-3.24%	-8.37%	-0.60%	-
Dividend Yield	1.90%	1.76%	0.91%	0.90%	0.38%	-
Payout Ratio	42.52%	29.37%	35.36%	31.43%	5.24%	-
Buyback Yield / Dilution	1.74%	-2.52%	-1.28%	-10.06%	-19.95%	1.06%
Total Shareholder Return	3.63%	-0.76%	-0.37%	-9.17%	-19.58%	1.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.